planner disclosure summary · planner disclosure summary name of individual individual's...

Planner Disclosure Summary

Name of Individual Individual's

Role(s) in

Activity

Name of Commercial Interest(s) Nature of Relationship(s)

Aerts, Joachim Education

Committee

1) BMS, Roche, Eli-Lilly, Boehringer Ingelheim, Takeda, MSD, Astra-

Zeneca, Amphera

2) Amphera

3) Allogenic Tumor-Cell Lysate, Combination Immunotherapy in

Oncology, Biomarker for Immunooncology

1) Advisory Board

2) Ownership or Stock Interest

3) Royalty, Intellectual

Property/Patent Holder

Aggarwal, Charu Planner 1) BMS, ROCHE, AZ, MERCK, Celgene

2) Allogenic tumor cell lysate/JAK inhibition in immuno-

oncology/biomarker for immuno-oncology (all institution)

1) Advisory Board

2) Royalties/Intellectual


Ahmed, Aneez Planner Nothing to disclose Nothing to disclose

Ahn, Myung-Ju Planner 1) Lilly, AstraZeneca, TAKEDA, Roche, BMS, Amgen

2) Lilly, AstraZeneca, TAKEDA, Roche, Alpha pharmaceutical

company

1) Advisory Board

2) Consultant

Aisner, Dara Planner 1) Presenter at CME Symposium for PeerView, Clinical Care

Options, Medscape (CME companies)

1) Other

Anantham,

Devanand

Planner Nothing to disclose Nothing to disclose

Andarini, Sita Planner 1) Astra Zeneca, Boehringer Ingelheim, MSD, Kalbe Innolab, Pfizer,

Roche, Takeda

2) Astra Zeneca, Boehringer Ingelheim, MSD, Roche

3) Astra Zeneca, Boehringer Ingelheim

1) Speakers Bureau

2) Advisory Board

3) Contracted/Supported Research

Grant

Ang, Mei-Kim Planner Nothing to disclose Nothing to disclose

Antonoff, Mara Planner Nothing to disclose Nothing to disclose

Araujo, Antonio Education

Committee

Nothing to disclose Nothing to disclose

Awad, Mark Planner 1) Achilles, Abbvie, Neon, Maverick, Blueprint

2) AstraZeneca, Lilly, Bristol-Myers Squibb, Genentech

1) Consultant


Grant

Baas, Paul Planner 1) MSD, BMS, Pfizer, AZ and Takeda

2) MSD, BMS

3) MSD, BMS, Roche

1) Advisory Board

2) Consultant


Grant

Babu, K. Govind CME Liaisons Nothing to disclose Nothing to disclose

Badawy, Ahmed Education

Committee


Baldwin, David Planner Nothing to disclose Nothing to disclose

of 16



Role(s) in

Activity


Barlesi, Fabrice Planner 1) Astra-Zeneca, Bayer, Bristol-Myers Squibb,

Boehringer–Ingelheim, Eli Lilly Oncology, F. Hoffmann–La Roche

Ltd, Novartis, Merck, MSD, Pierre Fabre, Pfizer and Takeda

2) Astra-Zeneca, Bayer, Bristol-Myers Squibb,

Boehringer–Ingelheim, Eli Lilly Oncology, F. Hoffmann–La Roche

Ltd, Novartis, Merck, MSD, Pierre Fabre, Pfizer and Takeda

3) Abbvie, ACEA, Amgen, Astra-Zeneca, Bayer, Bristol-Myers

Squibb, Boehringer–Ingelheim, Eisai, Eli Lilly Oncology, F.

Hoffmann–La Roche Ltd, Genentech, Ipsen, Ignyta, Innate Pharma,

Loxo, Novartis, Medimmune, Merck, MSD, Pierre Fabre, Pfizer,

Sanofi-Aventis and Takeda

1) Advisory Board

2) Consultant


Grant

Beattie, Vanessa Planner Nothing to disclose Nothing to disclose

Bironzo, Paolo Planner 1) BMS, MSD, BI, Astra Zeneca, Roche 1) Honorarium received from

promotional activities

Black, Kirsten Staff Liaison Nothing to disclose Nothing to disclose

Blackhall, Fiona Planner 1) Me Astra Zeneca

2) Me Abbvie Roche

3) Me AZ Cellgene Roche Amgen

4) me AZ Roche Amgen

1) Speakers Bureau

2) Advisory Board

3) Consultant


Grant

Blackmon, Shanda Planner 1) Olympus

2) Boston Scientific, medtronic, Olympus

3) Medtronic, TruFreeze

4) Esophageal Anastomotic Device- with Boston Scientific

1) Speakers Bureau

2) Advisory Board


Grant

4) Honorarium received from


Borghaei, Hossein Planner 1) Genentech, Celgene, Pfizer, Merck, Astra Zeneca, Novartis,

Genmab, Regeneron, BioNTech, Cantargia AB, Amgen, Axiom

2) Abbvie,BMS, Lilly,EMD-Serono,Boehringer Ingelheim, DSMB:

Takeda

3) Lilly

4) BMS/Lilly, Merck/Celgene, Millennium

1) Advisory Board

2) Consultant




Grant

Bubendorf, Lukas Planner 1) Boehringer Ingelheim, Astra Zeneca , Eli Lilly, Bayer

2) Roche, Novartis

3) Bayer

4) Roche

1) Advisory Board

2) Ownership/Stock Interest




Grant

of 16



Role(s) in

Activity


Cardona Zorrilla,

Andres Felipe

Planner 1) Roche, BI, Pfizer, Novartis, Astra, Amgen, BMS, MSD

2) Roche, BI, Pfizer, Novartis, Celldex, Astra Zeneca, Astellas,

Amgen, MSD, Merck Serono

3) Roche, BI, Pfizer, Novartis, Celldex, Astra Zeneca, Astellas,

Amgen, MSD, Merck Serono

4) Foundation for Clinical and Applied Cancer Research - FICMAC

5) Roche, BI, Novartis, BMS, Abbie, Celldex, Idilla, Termo Fisher,

Illumina

6) CLINICA DEL COUNTRY

7) Conquer Cancer Foundation

1) Speakers Bureau

2) Advisory Board

3) Consultant




6) Financial support or relationship

with tobacco and/or e-cigarette

company


Grant

Cedzynska,

Magdalena


Chaft, Jamie Planner 1) BMS, AZ, Genentech, Merck

2) BMS, AZ, Genentech, Merck

1) Advisory Board


Grant

Chan, Alexandre Planner Nothing to disclose Nothing to disclose

Chang, Yeun-

Chung


Cheng, Ying Planner Nothing to disclose Nothing to disclose

Chi, Alexander Planner 1) TK Healthcare 1) Financial support or relationship


company

Chiappori, Alberto Planner 1) Takeda, Merck, Novartis, Genentech, Celgene

2) Astra Zeneca, BMS, Novartis, Amgen, Pfizer

3) Takeda, Merck, Novartis, Genentech, Celgene

4) Astra Zeneca, BMS, Novartis

1) Speakers Bureau

2) Advisory Board




Grant

Chin, Venessa Planner 1) Myself, advisory board member, AstraZeneca

2) Myself, paid invited speaker at educational event, Bohringer

Ingelheim

1) Advisory Board

2) Other

Cho, Byoung Chul Planner 1) Norvatis(Recipient:You)

2) Novartis, Bayer, AstraZeneca, MOGAM Institute, Dong-A ST,

Champions Oncology, Janssen, Yuhan, Ono, Dizal Pharma,

MSD(Recipient:You)

3) Novartis, AstraZeneca, Boehringer-Ingelheim, Roche, BMS, Ono,

Yuhan, Pfizer, Eli Lilly, Janssen, Takeda, MSD(Recipient:You)

4) TheraCanVac Inc, Gencurix Inc, Bridgebio

therapeutics(Recipient:You)



MSD(Recipient:You)



MSD(Recipient:You)

7) Champions Oncology(Recipient:You)

1) Speakers Bureau

2) Advisory Board

3) Consultant





Grant



of 16



Role(s) in

Activity


Chou, Teh-Ying Planner 1) Roche

2) Roche

3) Roche

1) Speakers Bureau

2) Advisory Board

3) Consultant

Choy, Hak Planner 1) Merck, AZ 1) Advisory Board

Chua, Kevin Planner 1) Myself: Astrazeneca & Varian Medical Systems

2) Myself: Astrazeneca

3) Myself: National Cancer Centre Singapore

1) Speakers Bureau

2) Advisory Board

3) Employment

Chung, Jin-Haeng Planner Nothing to disclose Nothing to disclose

Cooper, Wendy Planner Nothing to disclose Nothing to disclose

Cui, Jiuwei Planner 1) The First Hospital of Jilin University 1) Financial support or relationship


company

Culligan, Melissa Planner 1) University of Maryland Medical Center 1) Financial support or relationship


company

Currow, David Planner 1) I am an unpaid advisory board member for Helsinn

Pharmaceuticals

2) I am a paid consultant and receives payment for intellectual

property with Mayne Pharma and a consultant with Specialised

Therapeutics Australia Pty. Ltd

1) Advisory Board

2) Consultant

Davies, Marianne Education

Committee


De Koning, Harry Planner Nothing to disclose Nothing to disclose

De Lima Lopes,

Gilberto


Degi, Csaba Education

Committee


Diehn, Maximilian Planner 1) AstraZeneca

2) Roche, BioNTech

3) CiberMed

4) Varian Medical Systems

5) Patents on cancer biomarkers

1) Advisory Board

2) Consultant



Grant



Donington, Jessica Planner 1) AstraZeneca

2) AstraZeneca

1) Speakers Bureau

2) Advisory Board

Dresler, Carolyn Planner Nothing to disclose Nothing to disclose

of 16



Role(s) in

Activity


Drilon, Alexander Planner 1) Me: Ignyta/Genentech/Roche, Loxo/Bayer/Lilly,

Takeda/Ariad/Millenium, TP Therapeutics, AstraZeneca, Pfizer,

Blueprint, Helsinn, Beigene, BergenBio, Hengrui, Exelixis, Tyra,

Verastem, MORE, Abbvie

2) Me (CME Honoraria): Medscape, OncLive, PeerVoice, Physicians

Education Resources, Targeted Oncology, Research to Practice,

Oncology

3) Me (Associated Research Paid to Institution): Pfizer, Exelixis,

GlaxoSmithKlein, Teva, Taiho, PharmaMar; Me (Research):

Foundation Medicine

4) Me: Wolters Kluwer (Pocket Oncology)

5) Me (Food/Beverage): Merck, Puma

1) Advisory Board




Grant



5) Other

Duma, Narjust Planner Nothing to disclose Nothing to disclose

Duruisseaux,

Michael

Planner 1) Astra Zeneca, MSD, Boerhinger Ingelheim, BMS, Abbvie,

Novartis, Takeda

1) Advisory Board

Ekman, Simon Planner Nothing to disclose Nothing to disclose

Fang, Wentao Planner Nothing to disclose Nothing to disclose

Faseru, Babalola Planner Nothing to disclose Nothing to disclose

Feller-Kopman,

David

Planner 1) AstraZeneca

2) Veran Medical, Veracyte Inc

3) Nuvaira

4) Trizell

1) Speakers Bureau

2) Consultant



Grant

Fong, Kwun Planner 1) CAD software provided for research trial by MeVIS 1) Other

Fraser, Anne Planner Nothing to disclose Nothing to disclose

Gaafar, Rabab Planner 1 ) AstraZeneca, Pfizer, Lilly Oncology

2) Protocol PI with NCI Cairo with Roche, Boehringer Ingelheim

and MSD

1) Speakers Bureau

2) Other

Gadgeel, Shirish Planner 1) Genentech/Roche, Astra-Zeneca, Pharmar, Takeda, Novocure,

Boehringer-Ingelheim, Xcovery

2) Travel Grant- Roche/Genentech

1) Advisory Board

2) Other

Gainor, Justin Planner 1) Bristol-Myers Squibb, Merck, Genentech/Roche, Takeda,

Blueprint, Loxo, Regeneron, Oncorus, Pfizer, Amgen

2) Ironwood Pharmaceuticals (Spouse)

3) Novartis, Takeda, Genentech/Roche

4) Employment - Ironwood Pharmaceuticals (spouse)

1) Advisory Board



Grant

4) Other

Galateau Salle,

Francoise


Ganti, Apar Kishor CME Liaisons 1) AstraZeneca

2) AstraZeneca, Genentech

3) Takeda (Research Support), Merck, Apexigen, Novartis

(Institutional PI on Multi-Center Trial)

1) Advisory Board

2) Consultant


Grant

of 16



Role(s) in

Activity


Garassino, Marina

Chiara

Planner 1) Otsuka Pharma, Incyte; Eli Lilly, BMS, Roche, Celgene,

Takeda; MSD, AstraZeneca; Takeda Russia.

2) Boehringer Ingelheim, Novartis, Pfizer, Inivata, Seattle

Genetics, Daiichi-Sankyo -Incyte; Eli Lilly, BMS, Roche, Celgene,

MSD, AstraZeneca, Takeda.

3) MSD, AstraZeneca;

4) Merck KGaA - AstraZeneca AB- UNITED THERAPEUTICS

CORPORATION- F. Hoffmann-La Roche, Ltd-Incyte Corporation-

Merck Sharp & Dohme Corporation- Novartis Farma S.p.A- TAKEDA

Pharmaceuticals-SPECTRUM PHARMACEUTICALS- Exelixis Inc.-

GlaxoSmithKline S.p.A. advisory role, Steering Committee;

research funding: Spectrum Pharmaceuticals, Blueprint Medicine.

5) Patent n°/ Application n° 19185724.2-1111 date: 03/09/2019

Immunotherapy in Advanced NSCLC

1) Speakers Bureau

2) Advisory Board

3) Consultant


Grant



Garon, Edward Planner 1) Dracen, EMD Serono, Novartis (me)

2) AstraZeneca, BMS, Eli Lilly, Genentech, Novartis, Merck, Neon,

Iovance, Dynavax, Mirati

1) Advisory Board


Grant

Gerber, David Planner 1) Gilead

2) Astra Zeneca, BerGenBio, Karyopharm, Sagimet

3) Oxford University Press, Decision Support in Medicine, Patent

pending: application number 62/461,455



Grant



Goldberg, Sarah Planner 1) AstraZeneca

2) Yale Cancer Center

3) AstraZeneca

1) Consultant



company


Grant

Goo, Jin Mo Planner 1) Infinitt Healthcare 1) Contracted/Supported Research

Grant

Goto, Yasushi Planner 1) AstraZeneca, Eli Lilly, Chugai, Taiho Pharmaceutical,

Boehringer Ingelheim, Ono Pharmaceutical, Bristol Myers Squibb,

Pfizer, MSD, Shionogi Pharma, Novartis

2) Eli Lilly, Chugai, Taiho Pharmaceutical, Boehringer

Ingelheim,Pfizer, Novartis, AstraZeneca, Glaxo Smith Kline, MSD,

Guardant Health

3) Abbvie, Eli Lilly, Taiho Pharmaceutical, Bristol Myers Squibb,

Ono Pharmaceutical, Dai-ichi Sankyo, Pfizer, Novartis, Kyorin,

Chugai, Guardant Health

1) Speakers Bureau

2) Advisory Board


Grant

Govindan,

Ramaswamy

Planner 1) Achilles 1) Advisory Board

Gray, Stacy Planner 1) Grail (me), Magenta (spouse) 1) Consultant

Guckenberger,

Matthias

Planner 1) AstraZeneca 1) Advisory Board

Hamzah, Ednin Planner Nothing to disclose Nothing to disclose

Hatton, Matthew Education

Committee


of 16



Role(s) in

Activity


Horinouchi,

Hidehito

Planner 1) AstraZeneca, ONO, BMS, Lilly, Ilumina

2) AstraZeneca, ONO, BMS, Lilly, MSD, Taiho, Kyowa-Kirin, Chugai,

Roche

3) Daiichi-Sankyo, Abbvie, ONO, BMS, MSD, Chugai, Roche

1) Advisory Board




Grant

Horn, Leora Planner 1) Astra Zeneca, Merck, Incyte, Genentech-Roche, Xcovery, EMD

Serono, Pfizer

2) Xcovery, Amgen

3) Xcovery, Bristol Myers Squibb, Boehringer Ingelheim

4) Travel to speak at meetings Bristol Myers Squibb, Xcovery

1) Advisory Board

2) Consultant


Grant

4) Other

Huang, Yiqing Planner Nothing to disclose Nothing to disclose

Hwangbo, Bin Planner Nothing to disclose Nothing to disclose

Ihsan, Alloubi CME Liaisons Nothing to disclose Nothing to disclose

Jacobsen

Skanderup, Anders


Jain, Amit Planner Nothing to disclose Nothing to disclose

Jain, Deepali Planner Nothing to disclose Nothing to disclose

Jassem, Jacek Planner 1) AstraZeneca, Roche, Pfizer

2) AstraZeneca, BMS, Pfizer, MSD, Takeda

3) Roche, Pfizer travel support

1) Speakers Bureau

2) Advisory Board

3) Other

Johnson, Melissa Planner 1) & 2) Genentech/Roche, Celgene, Boehringer Ingelheim, Sanofi,

Mirati, LOXO, Calithera, AstraZeneca, Merck, Araxes Pharma,

Mersana Therapeutics, BeiGene, Incyte, Pfizer, GUardant Health,

Bristol Myers-Squibb, Ribon Therapeutics

3) Research Funding - BerGenBio, Lilly, EMD Serono, Janssen,

Mirati Therapeutics, Genmab, Pfizer, AstraZeneca,

Genentech/Roche, StemCentrix, Novartis, Checkpoint

Therapeutics, Array, Regeneron, Apexigen, Abbvie, Tarveda,

Adaptiummune, Syndax, Neovia, Boehringer Ingelheim, Sanofi,

Hengrui Therapeutics, Merck, Daiichi Sankyo, Lycera, G1

Therapeutics, Dynavax, LOXO, CytomX, BeiGene, Birdie, Corvus,

Incyte, Genocea, Gritstone, Amgen, Bristol Myers-Squibb,

Kadmon, Clovis, Acerta, OncoMed, Guardant Health, Takeda,

Shattuck Labs, GlaxoSmithKline

4) Abbvie, Astellas, AstraZeneca, Boehringer Ingelheim, Clovis,

Daiichi Sankyo, EMD Serono, Bristol Myers-Squibb, Exelixis,

Genentech, Incyte, Merck, Pfizer, Sysmex Inostics, Vapotherm

1) Advisory Board

2) Consultant


Grant

4) Other

of 16



Role(s) in

Activity


Joubert, Philippe Planner 1) Bristol-Myers Squibb

2) AstraZeneca

3) Université Laval

4) AstraZeneca, Pfizer

1) Advisory Board

2) Consultant



company


Grant

Kao, Steven Planner 1) Pfizer, Astra Zeneca, Roche, MSD, Boehringer

2) Pfizer, Astra Zeneca, Roche, MSD, BMS

3) Astra Zeneca, Pfizer

1) Advisory Board




Grant

Kazmi, Shayma Education

Committee


Kelly, Karen Planner 1) AbbVie, AstraZeneca, EMD Serono, Inivata, Novartis,

Regeneron, Symphogen

2) Data Monitoring Committee, AstraZeneca

3) AbbVie, EMD Serono, Genentech, Regeneron

4) UpToDate

5) Speaker, Merck, Educational Lectures (not speakers bureau)

1) Advisory Board

2) Consultant


Grant



5) Other

Kerr, Keith Planner 1) AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli

Lilly, Merck Serono, Merck Sharp & Dohme, Novartis, Pfizer,

Roche, Ventana, PER, Prime Oncology

2) AbbVie, Amgen, Archer diagnostics, AstraZeneca, Bayer,

Boehringer Ingelheim, Bristol-Myers Squibb, Merck Serono, Merck

Sharp & Dohme, Novartis, Pfizer, Roche,

1) Speakers Bureau

2) Advisory Board

Kidane, Biniam Planner Nothing to disclose Nothing to disclose

Kim, Hye Ryun Planner Nothing to disclose Nothing to disclose

Kim, Young Tae Planner Nothing to disclose Nothing to disclose

King, Jennifer Planner 1) Foundation Medicine

2) GRAIL, Merck

3) Foundation Medicine, ThermoFisher, AstraZeneca

1) Advisory Board

2) Consultant



Klebe, Sonja Planner 1) Advisory Board to advise on pathology testing in lung cancer in

Australia for MERCK. leading to publication

2) Have participated in Educational activities supported by/paid

for Astra Zeneca and Ventana Roche (no honorarium) have

received funds for research testing various antibodies for diagnosis

is lung cancer (investigator-initiated study) from Ventana/Roche, I

have received a drug to test for research from Signpath Pharma

(only drug, called lipocurc TM no funding for actual study which

was independently funded by a grant)

1) Advisory Board

2) Other

Koh, Wee Yao Planner Nothing to disclose Nothing to disclose

Kong, Feng-Ming

(Spring)

Planner 1) AstraZeneca, Roche

2) Hong Kong University and Case Western Reserve University

3) Varian Medical Inc.

1) Speakers Bureau

2) Employment


Grant

of 16



Role(s) in

Activity


Koong, Heng Nung Planner Nothing to disclose Nothing to disclose

Labuc, Pippa Planner Nothing to disclose Nothing to disclose

Lai, Gillianne Planner 1) $1000 SGD from Pfizer for NCCS-COE Lung and GU preceptorship 1) Honorarium received from


Lai, Yeur-Hur Planner Nothing to disclose Nothing to disclose

Leal, Ticiana Planner 1) AstraZeneca, Bayer, BeyondSpring, Bristol-Myers Squibb, Merck,

Takeda, Genentech

2) AstraZeneca, Novocure (Steering Committee LUNAR study)

1) Advisory Board

2) Consultant

Lee, Jay Planner 1) Genentech, AstraZeneca, Novartis

2) Merck

1) Advisory Board


Grant

Lee, Pyng Planner Nothing to disclose Nothing to disclose

Leigh, Lillian Planner Nothing to disclose Nothing to disclose

Leighl, Natasha Planner Nothing to disclose Nothing to disclose

Li, Bob Planner 1) Guardant Health, Hengrui Therapeutics

2) Genentech, AstraZeneca, Daiichi Sankyo, Hengrui Therapeutics,

Amgen

1) Consultant


Grant

Liam, Chong Kin Planner 1) AstraZeneca, Merck Sharp & Dohme, Boehringer Ingelheim

2) AstraZeneca, Merck Sharp & Dohme, Boehringer Ingelheim,

Pfizer

3) University of Malaya

4) AstraZeneca, Boehringer Ingelheim

1) Speakers Bureau

2) Advisory Board



company


Grant

Licht, Peter Planner 1) Ethicon Johnson&Johnson: ad hoc proctor in minimally invasive

thoracic surgery in Europe

1) Other

Liew, Charlene Planner 1) Changi General Hospital 1) Financial support or relationship


company

Lim, Eric Planner 1) Pfizer, Roche, Lily Oncology, Boehringer Ingelheim, Ethicon

2) AstraZeneca, Medtronic

3) Abbott Molecular, Glaxo Smith Kline

4) Medela

5) Medela, Clearbridge Biomedics, Illumina, Guardant Health

5) Clearbridge Biomedics

1) Speakers Bureau

2) Advisory Board

3) Consultant




Grant



Lin, Chia-Chi Planner 1) Novartis

2) Daiichi-Sankyo, Kelun

3) Roche

1) Advisory Board

2) Consultant



Lin, Dongmei Planner Nothing to disclose Nothing to disclose

of 16



Role(s) in

Activity


Liu, Stephen Planner 1) Apollomics, AstraZeneca, Bristol-Myers Squibb, Celgene, G1

Therapeutics, Genentech, Guardant Health, Lilly, LOXO,

PharmaMar, Roche, Takeda/Ariad, Tempus

2) AstraZeneca, Celgene, Genentech, Janssen, Lilly, MSD, Roche,

Takeda

3) Alkermes, AstraZeneca, Bayer, Blueprint, Bristol-Myers Squibb,

Clovis, Corvus, Debiopharm, Esanex, Genentech/Roche, Ignyta,

Lilly, Lycera, Merck, Molecular Partners, OncoMed, Pfizer, Rain

Therapeutics, Turning Point Therapeutics

1) Advisory Board

2) Consultant


Grant

Lockwood, William Planner 1) British Columbia Cancer Agency 1) Financial support or relationship


company

Lohinai, Zoltan Planner Nothing to disclose Nothing to disclose

Lok, Benjamin Planner Nothing to disclose Nothing to disclose

Loong, Herbert Education

Committee

1) Boehringer Ingelheim, Eisai, Eli-Lilly

2) Eisai, Novartis

3) MSD, Mundipharma, Novartis

1) Advisory Board

2) Speakers Bureau

3) Contracted/Support Research

Grant

Louie Alex Education

Committee

1) AstraZeneca

2) Varian Medical Systems Inc.

1) Advisory Board

2) Speakers Bureau

Lovly, Christine Planner 1) BLuePrints Medicine, Takeda, Genentech, Achilles, Foundation

Medicine

2) Foundation Medicine

3) Honorarium from Advisory Boards: BLuePrints Medicine, Takeda,

Genentech, Achilles, Foundation Medicine

1) Advisory Board

2) Consultant

3) Other

Lu, Shun Planner 1) Astra Zeneca

2) Astra Zeneca, Roche, Hutchison MediPharma,

3) BMS, Zai Lab

1) Speakers Bureau

2) Advisory Board

3) Consultant

Lu, You Planner 1) Consulting/advisory role, AstraZeneca; Pfizer; Bristol-Myers

Squibb; Merck Sharp & Dohme; Roche/Genentech

2) Supported research grant role, AstraZeneca; Pfizer

1) Consultant


Grant

Madabhushi, Anant Planner 1) Self, Inspirata Inc.,

2) Self, Inspirata Inc, Merck, Bristol-Meyers Squibb

3) Self, Inspirata Inc, Elucid Bioimaging

4) Self, Philips

5) Self, Inspirata Inc.

1) Advisory Board

2) Consultant



Grant



Madegedara,

Dushantha


Mcwilliams,

Annette

Planner 1) Travel support by Roche- I was an invited speaker to attend a

Study day in Sydney Australia- Roche paid fro travel and

accommodation. Cancer Australia has also provided travel support

to attend workshops in Syndey. I have also received travel and

accommodation support from Olympus to attend an annual

research meeting in Australia + New Zealand.

1) Other

of 16



Role(s) in

Activity


Meldgaard, Peter Planner Nothing to disclose Nothing to disclose

Mezquita, Laura Planner 1) Tecnofarma

2) Roche, Takeda

3) Mentorship Program funded by AstraZeneca

1) Speakers Bureau

2) Advisory Board

3) Other

Mohindra Pranshu Education

Committee


Molassiotis, Alex Planner Nothing to disclose Nothing to disclose

Mori, Masanori Planner Nothing to disclose Nothing to disclose

Morris, Lucinda Planner Nothing to disclose Nothing to disclose

Murgu, Septimiu Planner 1) Olympus, Boston Scientific, Pinnacle Biologics and Cook Inc

2) Elsevier ( for textbook on Bronchoscopy)

3) Chair of Education Committee for CHEST and President-elect

AABIP

1) Consultant



3) Other

Nagata, Yasushi Planner Nothing to disclose Nothing to disclose

Nakagawa,

Kazuhiko

Planner 1) Astellas Pharma Inc./Takeda Pharmaceutical Co.,Ltd.

2) "Astellas Pharma Inc./Takeda Pharmaceutical

Co.,Ltd./AstraZeneca K.K./Chugai Pharmaceutical Co.,Ltd./ MSD

K.K./Eli Lilly Japan K.K. /Ono Pharmaceutical Co.,Ltd./Nippon

Boehringer Ingelheim Co.,Ltd./ Daiichi Sankyo Co., Ltd./Novartis

Pharma K.K. / Taiho Pharmaceutical Co.,Ltd./Pfizer Japan

Inc./Bristol Myers Squibb Company/Nikkei Business Publications,

Inc./KYORIN Pharmaceutical Co.,Ltd./MEDICUS

SHUPPAN,Publishers Co., Ltd. /CareNet,Inc/Thermo Fisher

Scientific K.K. /Nichi-Iko Pharmaceutical Co., Ltd./NANZANDO

Co.,Ltd/ Hisamitsu Pharmaceutical Co.,Inc./Medical Review Co.,

Ltd. / YODOSHA CO., LTD./YOMIURI TELECASTING CORPORATION."

3) "MSD K.K./AstraZeneca K.K./ICON Japan K.K./Astellas Pharma

Inc./Takeda Pharmaceutical Co.,Ltd./Novartis Pharma K.K./Eli

Lilly Japan K.K./Quintiles Inc./Bristol Myers Squibb Company/CMIC

Shift Zero K.K./ Taiho Pharmaceutical Co.,Ltd./Eisai Co., Ltd.

/PAREXEL International Corp./Nippon Boehringer Ingelheim

Co.,Ltd. / Ono Pharmaceutical Co.,Ltd./Kissei Pharmaceutical

Co.,Ltd./IQVIA./Pfizer Japan Inc./ A2 Healthcare Corp./Kyowa

Hakko Kirin Co.,Ltd / AbbVie Inc./EPS Corporation. / Chugai

Pharmaceutical Co.,Ltd./Daiichi Sankyo Co., Ltd./ SymBio

Pharmaceuticals Limited./Bayer Yakuhin, Ltd / Merck Serono

Co., Ltd."

1) Consultant




Grant

Nazareth Aguiar

Junior, Pedro


Neal, Joel Education

Committee

1) AstraZeneca, Eli Lilly, Exelixis, Genetech/Roche, Jounce

Therapeutics, Takeda

2) Adaptimmune, Boehringer Ingelheim, Exelixis,

Genetech/Roche, GSK, Merck, Nektar, Novartis, Takeda

1) Advisory Board


Grant

O'Hallahan, Jane Planner Nothing to disclose Nothing to disclose

of 16



Role(s) in

Activity


Ong, Boon-Hean Planner 1) I received a honorarium and travel expenses to attend an

international consensus meeting on use of ICG in thoracic surgery

in Hong Kong in July 2019 from Stryker. I also received

reimbursement for travel and accommodation to attend a thoracic

surgery workshop in Hong Kong in July 2019 from Johnson &

Johnson.

1) Other

Ortiz-Cuaran,

Sandra


Osarogiagbon, Ray Planner 1) Association of Community Cancer Centers

2) Eli Lilly, Pfizer

3) Owner of patents for surgical specimen collection kit.

1) Consultant




Ou, Sai-Hong Planner 1) Pfizer, Roche/Genentech, Takeda/ARIAD, Merck, Astra Zeneca

2) Pfizer, Roche/Genetech, Takeda/ARAID, Astrazeneca

3) Turning Point Therapeutics, AnHeart Therapeutics

4) Turning Point Therapeutics

5) Pfizer, Takeda/ARIAD, Roche, Astra Zeneca, Geneseeq

laboratories

1) Speakers Bureau

2) Advisory Board

3) Consultant




Owonikoko,

Taofeek

Planner 1) Novartis, Celgene, Lilly, Sandoz, Abbvie, Eisai, G1

Therapeutics, Takeda, Seattle Genetics, Bristol-Myers Squibb,

MedImmune, BerGenBio, Lilly, Amgen, AstraZeneca, PharmaMar,

Boehringer Ingelheim, EMD Serono, Xcovery, Bayer, Heron

Pharmaceutical, ARMO BioSciences, Merck, Bayer

2) Cambium Oncology

3) Novartis; Astellas Pharma, Bayer, StemCentRx, Regeneron,

AstraZeneca/MedImmune, Abbvie, G1 Therapeutics, Bristol-

Myers, Corvus Pharmaceuticals, United Therapeutics, Amgen,

Loxo/Lilly, Fujifilm, Pfizer, Aeglea Biotherapeutics, Incyte, Merck

1) Advisory Board



Grant

Oxnard, Geoffrey Planner 1) AstraZeneca, Blueprint, Illumina, Janssen, Genentech

2) DropWorks, Foundation Medicine

1) Advisory Board

2) Consultant

Pan-Chyr, Yang Planner Nothing to disclose Nothing to disclose

Pass, Harvey Planner 1) Wife: genentech and genomic health

2) Astra Zeneca; Novartis Roche; Loxo; Genentech

3) Biodesix, Co-factor Genomics, SomaLogic

4) NCI, mesothelioma cell lines; Patent for Osteopontin for

diagnosis of mesothelioma

1) Speakers Bureau

2) Advisory Board


Grant



Patel, Jyoti Education

Committee

1) AbbVie, AstraZeneca, Takeda 1) Consultant

of 16



Role(s) in

Activity


Peters, Solange Planner 1) Abbvie, Amgen, AstraZeneca, Bayer, Biocartis, Bioinvent,

Blueprint Medicines, Boehringer-Ingelheim, Bristol-Myers Squibb,

Clovis, Daiichi Sankyo, Debiopharm, Eli Lilly, F. Hoffmann-La

Roche, Foundation Medicine, Illumina, Janssen, Merck Sharp and

Dohme, Merck Serono, Merrimack, Novartis, Pharma Mar, Pfizer,

Regeneron, Sanofi, Seattle Genetics and Takeda

2) Stallites symposia only: AstraZeneca, Boehringer-Ingelheim,

Bristol-Myers Squibb, Eli Lilly, F. Hoffmann-La Roche, Illumina,

Merck Sharp and Dohme, Novartis, Pfizer, Sanofi, Takeda

3) (Sub)investigator in trials (institutional financial support for

clinical trials) sponsored by Amgen, AstraZeneca, Biodesix,

Boehringer-Ingelheim, Bristol-Myers Squibb, Clovis, F. Hoffmann-

La Roche, Illumina, Merck Sharp and Dohme, Merck Serono,

Novartis, and Pfizer

1) Advisory Board




Grant

Pilotto, Sara Planner 1) AstraZeneca, MSD, Boehringer Ingelheim, BMS, Roche

2) MSD, Boehringer Ingelheim, BMS

3) Boehringer Ingelheim, Roche, TRM Oncology

4) AstraZeneca

1) Speakers Bureau

2) Advisory Board

3) Consultant


Grant

Popat, Sanjay Planner 1) BMS, Roche, Takeda, AstraZeneca, Chugai, Novartis, Pfizer,

MSD, EMD Serono, Guardant Health, AbbVie, Boehringer Ingelheim,

Tesaro, Incyte

2) BMS, Roche, Takeda, AstraZeneca, Chugai, Novartis, Pfizer,

MSD, EMD Serono, Guardant Health, AbbVie, Boehringer Ingelheim,

Tesaro, Incyte

3) Elsevier

1) Advisory Board

2) Consultant

3) Employment

Qu, Melody Planner Nothing to disclose Nothing to disclose

Quist, Morten Planner 1) 1971 1) Financial support or relationship


company

Reck, Martin Planner 1) Amgen, AstraZeneca, BMS, Boehringer-Ingelheim, Celgene,

Lilly, Merck, MSD, Novartis, Pfizer, Roche

2) Amgen, AstraZeneca, BMS, Boehringer-Ingelheim, Celgene,

Lilly, Merck, MSD, Novartis, Pfizer, Roche

3) BMS

1) Speakers Bureau

2) Advisory Board


Grant

Reguart, Noemi Planner 1) Astra-Zeneca, MSD, BI, Roche, BMS

2) Astra-Zeneca, Pfizer, MSD, Novartis, BI

3) Pfizer, Novartis

1) Speakers Bureau

2) Advisory Board


Grant

Reinmuth, Niels Planner 1) Astra Zeneca, Böhringer-Ingelheim, BMS, Roche, MSD, Takeda,

Abbvie

2) Astra Zeneca, Böhringer-Ingelheim, BMS, Roche, MSD, Takeda,

Abbvie

1) Speakers Bureau

2) Advisory Board

Ren, Shengxiang Education

Committee


of 16



Role(s) in

Activity


Reungwetwattana,

Associate

Professor

Thanyanan

Planner 1) Astrazeneca, Roche, Novartis, MSD

2) Astrazeneca, Roche, Novartis, MSD

1) Advisory Board


Grant

Rolfo, Christian

Diego

Education

Committee

1) Mylan, Oncompass

2) MSD, GuardantHealth

3) OncoDNA, Biomark, Guardanthealth

1) Advisory Board

2) Honorarium


Grant

Samol, Jens Planner Nothing to disclose Nothing to disclose

Samson, Pamela Planner Nothing to disclose Nothing to disclose

Sands, Jacob Planner 1) Medtronic, AstraZeneca, Foundation Medicine, Guardant, Loxo,

Abbvie

1) Advisory Board

Santini, Fernando Planner 1) AstraZeneca; MSD; Bayer

2) Lilly; Bayer; MSD; AstraZeneca

3) Roche; MSD; Bayer; AstraZeneca; BMS; Novartis

1) Speakers Bureau

2) Advisory Board



Schalper, Kurt Planner 1) Merck, Bristol Myers Squibb and Fluidigm

2) Celgene, Shattuck Labs, Pierre-Fabre, Astrazeneca, Dynamo

Therapeutics and Agenus

3) Clinica Alemana Santiago, Moderna Therapeutics, EMD Serono,

Takeda, Torque Therapeutics

4) Yale University

5) Navigate Bipharma (Novartis), Vasculox/Tioma, Tesaro,

Moderna Thrapeutics, Takeda Pharmaceuticals, Surface Oncology,

Pierre-Fabre Research Institute, Merck, Bristol-Myers Squibb,

AstraZeneca and Eli Lilly.

1) Speakers Bureau

2) Advisory Board

3) Consultant

4) Employment


Grant

Schoenherr, Grit Planner Nothing to disclose Nothing to disclose

Sholl, Lynette Planner 1) LOXO Oncology

2) AstraZeneca

3) Roche/Genentech

1) Advisory Board




Grant

Singh, Navneet Planner Nothing to disclose Nothing to disclose

Skoulidis,

Ferdinandos

Planner 1) Tango Therapeutics 1) Consultant

Soo, Ross Planner 1) Astra-Zeneca, BMS, Boehringer Ingelheim, Lilly, Merck,

Novartis, Pfizer, Roche, Taiho, Takeda, Yuhan

2) Astra-Zeneca, Boehringer Ingelheim

1) Advisory Board


Grant

Steliga, Matthew Planner Nothing to disclose Nothing to disclose

Stone, Emily Planner 1) Non-financial support: Boehringer-Ingelheim - travel and

accommodation to attend AIRWAYS 2019

1) Other

Suarez, Francisco Education

Committee


Suda, Kenichi Planner 1) Boehringer Ingelheim (myself)

2) AstraZeneca (myself)

3) Rain Therapeutics and Boehringer Ingelheim (myself)

1) Speakers Bureau

2) Advisory Board


Grant

of 16



Role(s) in

Activity


Takano, Angela Planner Nothing to disclose Nothing to disclose

Tam, Wai Leong Planner Nothing to disclose Nothing to disclose

Tan, Daniel Education

Committee

1) Pfizer, Novartis, AstraZeneca, Celgene, MSD, Takeda, Loxo,

Merrimack

2) Merck, Roche, Pfizer

3) Novartis, GSK, Astra Zeneca

1) Advisory Board

2) Honorarium

3) Novartis, GSK, AstraZeneca

Tan, Wan Ling Planner 1) National Cancer Centre Singapore 1) Financial support or relationship


company

Tanaka, Yuko Planner Nothing to disclose Nothing to disclose

Tenda, Dr Eric

Daniel


Tsao, Anne Planner 1) BMS, Eli Lilly, Genentech, Roche, Novartis, Ariad, EMD Serono,

Merck, Seattle Genetics, Astra-Zeneca, Boehringer-Ingelheim,

Sellas Life Science, Takeda, Epizyme, Huron

2) MD Anderson cancer center

3) Eli Lilly, Millennium, Polaris, Genentech, Merck, Boehringer-

Ingelheim, BMS, Ariad, Epizyme, Seattle Genetics, Takeda, EMD

Serono

1) Advisory Board

2) Employment


Grant

Turna, Akif Planner Nothing to disclose Nothing to disclose

Vallone, Stefania Planner Nothing to disclose Nothing to disclose

Warren, Graham Planner 1) Medical University of South Carolina 1) Financial support or relationship


company

Watanabe, Shun-

Ichi


Wolf, Andrea Planner Nothing to disclose Nothing to disclose

Wozniak,

Antoinette

Education

Committee

1) Boehringer Ingelheim

2) Karyopharm, HUYA, BeyondSpring

3) Boehringer Ingelheim

1) Advisory Board

2) Consultant


Grant

Wu, Ning Planner Nothing to disclose Nothing to disclose

Wu, Yi-Long Planner 1) AstraZeneca; Boehringer Ingelheim;

2) Speaker fees from AstraZeneca, Roche, Boehringer Ingelheim;

Pfizer; BMS; MSD; Eli Lilly (all not promotional activities)

3) AstraZeneca, Roche, Boehringer Ingelheim

1) Advisory Board




Grant

Yamaoka, Satoko Planner Nothing to disclose Nothing to disclose

Yang, Fan Planner Nothing to disclose Nothing to disclose

Yang, Grace Planner 1) National Cancer Centre 1) Financial support or relationship


company

of 16



Role(s) in

Activity


Yang, James Chih-

Hsin

Planner 1) Boehringer Ingelheim, Eli Lilly, Bayer,

Roche/Genentech/Chugai, MSD, Merck Serono, Pfizer, Novartis,

Celgene, Yuhan Pharmaceuticals, BMS, Ono pharmaceutical,

Daiichi Sankyo, Astrazeneca, Takeda Oncology and Hansoh

Pharmaceutical

2) Boehringer Ingelheim, Merck Serono, Novartis, Yuhan

Pharmaceuticals, BMS, Ono pharmaceutical, Daiichi Sankyo,

Astrazeneca and Takeda Oncology

1) Advisory Board

2) Consultant

Yano, Seiji Planner 1) AstraZeneca, Chugai Pharma, Taiho Pharma, Novartis,

Boehringer-Ingelheim, Pfizer

2) Chugai Pharma, Boehringer-Ingelheim, Novartis, Taiho Pharma,

Pfizer, MSD, Bayer, Daiichi-Sankyo, Shionogi, Eisai, Ohtsuka

1) Speakers Bureau


Grant

Yatabe, Yasushi Planner 1) MDS, Chugai-pharma, Novartis, Pfizer, AstraZeneca 1) Speakers Bureau

Ynoe De Moraes,

Fabio


Yom, Sue Education

Committee


Yorke, Janelle Planner 1) Nellie primary 1) Financial support or relationship


company

Zhang, Li Planner 1) MSD, AZ, Pfizer, Henrui Pharm

2) AZ, MSD, BMS

1) Speakers Bureau

2) Advisory Board

Zhong, Wen-Zhao Education

Committee

1) AstraZeneca 1) Speakers Bureau

Zhou, Caicun Education

Committee

1) Roche, Eli Lily, Boehringer Ingelheim, Merck, Hengrui, Qiru 1) Honorarium

Zhou, Qing Planner 1) I received honoraria from AstraZeneca, Roche. 1) Honorarium received from


of 16

planner disclosure summary · planner disclosure summary name of individual individual's...

Documents